Christine M. Arcari, PhD, MPH serves as a member of the Sealy Center for Vaccine Development (SCVD) Executive Committee. She is an Associate Professor in the Department of Preventive Medicine and Community Health at the University of Texas Medical Branch, Galveston. Dr. Arcari received her MPH from the University of South Florida, College of Public Health and her Ph.D. from the Johns Hopkins University Bloomberg School of Public Health. Dr. Arcari's interest is in the prevention and control of infectious and chronic diseases. Her focus is on implementing evidence- and practice-based policy, environmental, programmatic and infrastructure changes to transform the health and wellness of the community through the power of prevention. She is the Director of the Public Health Graduate Program which provides public health training (MPH degree) for health professionals and researchers.
Alan DT Barrett, PhD, serves as Director of the SCVD. As such, Dr. Barrett provides scientific direction for the SCVD's research programs. He is a world-renowned expert in the biology of flaviviruses. His research efforts have led to forty extramurally funded projects. He has published over 150 peer-reviewed journal articles - most of which are related to the molecular characterization/development of vaccines. He completed his 5-year term as an editor of the Journal of General Virology in December 2009 and became an Associate Editor for the journal Vaccine in January 2010. He is a member of the editorial boards of Journal of Virology, Journal of General Virology, Journal of Virological methods, Virus Research, Journal of Medical Virology and the Pan Amazonian Health Journal. He spent five years on the World Health organization (WHO) Advisory Committee for vaccines against dengue and other flavivirus diseases, including four years as chair. He has been a member of a number of WHO working groups for yellow fever, dengue, Japanese encephalitis and tick-borne encephalitis vaccines, and is a member of the Virus Diseases Panel of the Department of Defense Military Infectious Diseases Research program.
David WC Beasley, PhD, serves as a member of the SCVD Executive Committee. Dr. Beasley is an internationally recognized expert in the field of molecular biology of flaviviruses. His research focuses on the plasticity of flavivirus envelope protein sequences and the molecular basis for phenotypic variations between individual strains and major groups of flaviviruses, with the goal of developing and evaluating new and improved vaccines, diagnostics and therapeutics. He also served as a Co-Director of the University of Texas Medical Branch's (UTMB's) select agent BSL-3 laboratories and was the Director of the Galveston National Laboratory Regulatory Compliance Core. Dr. Beasley has been actively involved in UTMB's preparations for conduct of regulated nonclinical studies at BSL3/4 since 2005, with an emphasis on development and use of animal models for testing and approval of new vaccines and therapeutics under the FDA's Animal Rule.
Krystyn Z Bourne, PhD
Krystyn Z Bourne, PhD, serves as Assistant Director and as a member of the Executive Committee for the SCVD. She is responsible for organizing and monitoring the research and operational activities; maintaining contacts with external organizations that have an interest in SCVD programs. She also assembles information required for SCVD profiles, annual reports, and internal and external reviews and manages special projects such as a distance learning course development, pre- and postdoctoral fellowship applications, and an annual seminar series and recurring symposia.
Andrew G McNees, PhD, MBA
Andrew G McNees, PhD, MBA, serves as Director, Administration, and as a member of the Executive Committee for the SCVD. He is responsible for serving as a liaison with various entities both on campus and off; overseeing budgets and support staff; preparing grants, contracts, reports and manuscripts; facilitating the ordering of supplies and equipment; and organizing logistics support for the center as a whole. In addition, Dr. McNees compiles data and reports the status of ongoing projects to Dr. Barrett for review.
Gregg N Milligan, PhD, serves as a member of the SCVD Executive Committee. He is an expert in the field of viral immunology and currently directs NIH-funded research projects dealing with identification of protective correlates of immunity against genital herpes virus infections and with the link between innate and adaptive immune responses in flavivirus infections. Dr. Milligan is active in the education of graduate and medical students.
Lisa M Reece, PhD
Lisa M Reece, PhD, serves as Assistant Director for the WHO Collaborating Center for Vaccine Research, Evaluation and Training on Biodefense and Emerging Infectious Diseases and as a member of the SCVD Executive Committee.
Richard Rupp, MD is the Director of Clinical Trials and Clinical Research and a member of the Executive Committee for the SCVD. He leads the SCVD Clinical Trials Group, and is a Principal Investigator for clinical trials, Phase I to IV, in both pediatric and adult populations. Vaccines studied have included those protecting against human cytomegalovirus, seasonal, avian and pandemic influenza, pneumococcal disease, human papillomavirus, Dengue, varicella, Herpes simplex 2, and meningococcal disease.
Pei-Yong Shi, PhD, has pioneered flavivirus drug discovery in leading pharmaceutical companies and academia. He is also an internationally recognized leader in the field of flavivirus biology and vaccine development. He has published over 210 peer-reviewed articles and served as Editor (ACS Infectious Diseases, Journal of General Virology, and NPJ Vaccine) and Editorial Board member (Journal of Virology, Virology, and Antiviral Research). Dr. Shi’s lab integrates both academic and industrial expertise for basic and translational research.